Mitsui Chemicals Looks to Enter Sepsis Diagnostics Market Jun. 30, 2022 Filed Under: Pharma Tagged With: diagnostics, health care, medical, Mitsui Chemicals, sepsisMitsui Chemicals Inc. (TYO:4183) is gearing up to enter the business of manufacturing and selling in vitro diagnostic reagents in…... Please subscribe to read the full story. Subscribe Free Trial Related Articles:Mitsui Chemicals Places Heightened Emphasis on Medical…Mitsui Chemicals to Enter Orthopedics MarketJSR Set to Offer Pre-Clinical Trial Services Using Cancer…Daicel Targets 2024 for Launch of Centralized Medical…Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO MarketMitsui Chemicals to Use 3D Printing for Global Rollout of…